Details for 2018821779

Up to date per 01.04.2026

Actions

Title / Product Name

KRISTALLINE FORMEN VON N-(4-(4-(CYCLOPROPYLMETHYL)PIPERAZIN-1-CARBONYL)PHENYL)CHINOLIN-8-SULFONAMID

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018821779

EP Publication Number

3713919

E-Number

1594628

Language

PCT Number

US18062197

Publication Date

30.09.2020 A

02.08.2023 B1

Registration Date

02.08.2023

AT Publication Date

15.08.2023

Application Date

21.11.2018

Registration Number

Priorities

22.11.2017

201762589822 P

29.06.2018

201862691709 P

IPC

C07D 215/36 20060101AFI20190531BHEP

Maximum Duration of Protection

21.11.2038

Owner

Agios Pharmaceuticals, Inc.88 Sidney Street Cambridge, MA 02139US

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

SIZEMORE, Jacob, P.8 Vista Drive Shrewsbury MA 01545US

GUO, LitingQinshui Langting Blvd. 18 2 HongFan Road Suzhou Industrial Park Suzhou 215000CN

MIRMEHRABI, Mahmoud36 Roxbury Crescent Halifax Nova Scotia B3M 4T1CA

SU, Yeqing2225 Monastery Lane Apt 310 Halifax Nova Scotia B3L 4R1CA

Information about Fees